Stirling Griff (SA, Nick Xenophon Team) Share this | Hansard source

My question is to Senator Fierravanti-Wells, representing the Minister for Health. I refer the minister to the prostheses pricing agreement with the Medical Technology Association of Australia, which took effect from last month. In this agreement the government committed to reduce the time to market for implantable devices by removing the current requirement for clinical evidence with two years of follow-up data for some devices. Is there a reason that the government is exposing consumers to increased risks from prostheses that have not been demonstrated via two years of safety data?